Abstract
The treatment of viral infections has relied on pre-emptive vaccination or use of a limited range of anti-viral drugs. However, the majority of viruses have no available drugs and treatment is merely supportive. RNA interference (RNAi) offers the ability to directly and rapidly treat virus infections via the targeting of viral genes. Indeed, clinical trials have already been undertaken with promising results. Here we review the current state of the RNAi field for the treatment of viral infections such as HIV, human papillomavirus and HCV. We also review novel strategies including the concept of targeting self-genes to limit viral infection and activating the immune system for improved outcomes. Finally we examine innovative approaches being pursued at the Australian Infectious Diseases Research Centre including the use of highthroughput siRNA screens to identify new antiviral targets.
Keywords: HCV, HIV, HPV, RNA interference, screening, viral infections, siRNA, viral genes, human papillomavirus, short-hairpin RNA.
Current Drug Targets
Title:RNA Interference for Viral Infections
Volume: 13 Issue: 11
Author(s): Stephen J. Blake, Fawzi F. Bokhari and Nigel A.J. McMillan
Affiliation:
Keywords: HCV, HIV, HPV, RNA interference, screening, viral infections, siRNA, viral genes, human papillomavirus, short-hairpin RNA.
Abstract: The treatment of viral infections has relied on pre-emptive vaccination or use of a limited range of anti-viral drugs. However, the majority of viruses have no available drugs and treatment is merely supportive. RNA interference (RNAi) offers the ability to directly and rapidly treat virus infections via the targeting of viral genes. Indeed, clinical trials have already been undertaken with promising results. Here we review the current state of the RNAi field for the treatment of viral infections such as HIV, human papillomavirus and HCV. We also review novel strategies including the concept of targeting self-genes to limit viral infection and activating the immune system for improved outcomes. Finally we examine innovative approaches being pursued at the Australian Infectious Diseases Research Centre including the use of highthroughput siRNA screens to identify new antiviral targets.
Export Options
About this article
Cite this article as:
J. Blake Stephen, F. Bokhari Fawzi and A.J. McMillan Nigel, RNA Interference for Viral Infections, Current Drug Targets 2012; 13(11) . https://dx.doi.org/10.2174/138945012803530161
DOI https://dx.doi.org/10.2174/138945012803530161 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |

- Author Guidelines
- Editorial Policies
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Allegations from Whistleblowers
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Reviewer Guidelines
- Guest Editor Guidelines
- Board Recruitment Workflow
- Short Guide for New Editors
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Meet Our Editorial Board Member
Current Neuropharmacology Nitric Dioxide as Biologically Important Radical and its Role in Molecular Mechanism of Pancreatic Inflammation
Current Pharmaceutical Analysis Human A3 Adenosine Receptor as Versatile G Protein-Coupled Receptor Example to Validate the Receptor Homology Modeling Technology
Current Pharmaceutical Design In Silico Study of Chromatographic Lipophilicity Parameters of 3-(4-Substituted Benzyl)-5-Phenylhydantoins
Combinatorial Chemistry & High Throughput Screening Macrocyclic Inhibitors of HCV NS3-4A Protease: Design and Structure Activity Relationship
Current Topics in Medicinal Chemistry Computational Modeling Methods for QSAR Studies on HIV-1 Integrase Inhibitors (2005-2010)
Current Computer-Aided Drug Design Marine Derived Anticancer Drugs Targeting Microtubule
Recent Patents on Anti-Cancer Drug Discovery Copper as a Biocidal Tool
Current Medicinal Chemistry Predicting the Cumulative Number of Cases of the COVID-19 Epidemic in India from Early Data
The Natural Products Journal Synthesis and Biological Evaluation of Piperazinyl-2-(Benzo)thiophen/- furan-2-yl-acetonitriles as Strecker Reaction Products
Letters in Drug Design & Discovery The Interaction Network of MicroRNAs with Cytokines and Signaling Pathways in Allergic Asthma
MicroRNA Physiological and Pathophysiological Roles of ATP-Sensitive K+ Channels in Vascular Smooth Muscle
Vascular Disease Prevention (Discontinued) Fetal Encephalomalacia Secondary to Acute Maternal Blood Loss: A Case Study
New Emirates Medical Journal Recent Advances in Psoriasis Therapy: Trends and Future Prospects
Current Drug Targets Evaluating the Risk of Covid-19 Transmission from Conjunctival and Lacrimal Discharge: A Review
Current Biotechnology Editorial [Hot Topic: Recent Advances in Antiviral Agents (Executive Editor: Shin-Ru Shih)]
Current Pharmaceutical Design Therapeutic Applications of Fucoidans and their Potential to Act Against COVID-19
Current Pharmaceutical Design HIV Protease Inhibitors - The Next Generation
Current Medicinal Chemistry - Anti-Infective Agents Therapeutic Approaches for COVID-19 Based on the Interferon-Mediated Immune Responses
Current Signal Transduction Therapy The Cellular Effects of Carbon Monoxide in the Airway
Current Molecular Medicine